Clinical Trial Update: A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase II study of combining doxorubicin with Genexol-PM in patients with advanced/metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• Genexol-PM (paclitaxel)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN